Skip to main content
. 2022 Aug 18;13(11):e00518. doi: 10.14309/ctg.0000000000000518

Table 1.

Baseline characteristics

Baseline characteristic CRC (n = 30) AA (n = 138) NAA (n = 130) Controls (n = 84) P value
Age, yr ± SD 66.5 (5.7) 64.4 (7.4) 65.4 (4.9) 64.8 (8.6) NS
Male, n (%) 14 (46.7) 93 (67.4) 76 (58.5) 37 (44) a
BMI, kg/m2 ± SD 27.8 (5.6) 28 (4.8) 27.2 (4.7) 27.2 (4.7) b
Smoking, n (%) 3 (10) 22 (15.9) 15 (11.5) 8 (9.5) NS
 No 9 (30) 65 (47.1) 54 (41.5) 34 (40.5)
 Unknown 18 (60) 51 (37) 61 (47) 42 (50)
Alcohol, n (%) 5 (16.7) 48 (34.8) 40 (30.7) 24 (28.6) NS
 No 7 (23.3) 37 (26.8) 29 (22.3) 18 (21.4)
 Unknown 18 (60) 53 (38.4) 61 (47) 42 (50)
CRC TNM stadium, n (%)
 T1N0M0 12 (40)
 T2N0M0 7 (23.3)
 T3N0M0 3 (10)
 T1N1M0 1 (3.3)
 T2N1M0 3 (10)
 T3N1M0 4 (13.3)

AA, advanced adenoma; BBPS, Boston Bowel Preparation Scale; BMI, body mass index; CRC, colorectal cancer; NAA, nonadvanced adenoma; NS, not significant.

a

CRC vs AA (P = 0.032), AA vs controls (P = 0.001), NAA vs controls (P = 0.039).

b

AA vs controls (P = 0.026).